Oncorena in a SEK 66 million funding round backed by HealthCap Biotech Health services Manufacturing Pharma Investments 15 December 2021 Share:
Round value (USD): 7.25m Round investors: HealthCap Linc Invest Fåhraeus Startup and Growth Fund Company: Oncorena Industry: Biotech Health services Manufacturing Pharma
PharmNovo raised SEK 67 million from Sciety and Karolinska Development. Health services Pharma Investments 02 June 2022
Cellcolabs secured SEK 64 million from Norrsken VC and angel investors from Sweden. Biotech Health services Investments 20 March 2022
Sigrid Therapeutics secured investment capital of $8.4 million from a number of Sweden’s family offices Biotech Health services Investments 09 November 2021
Asgard Therapeutics scures €6 million from Novo Holdings, Boehringer Ingelheim Venture Fund and Industrifonden. Biotech Health services Pharma Investments 08 November 2021
Intrance Medical Systems to raise $8 million from Swedish real estate investor Erik Selin Fastigheter AB. Biotech Health services Manufacturing Pharma Investments 20 September 2021